CD8A and non-small cell lung carcinoma: Preclinical studies conducted in mice induced with NSCLC have revealed astounding results where it was evident that ART-1 modifies the P2RX7R receptor present on CD8 T cells triggering a signaling pathway that eventually leads to CD8 T cells’ death.